0001125345-23-000031.txt : 20230217
0001125345-23-000031.hdr.sgml : 20230217
20230217162811
ACCESSION NUMBER: 0001125345-23-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karrels James
CENTRAL INDEX KEY: 0001587477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 23643032
MAIL ADDRESS:
STREET 1: 9640 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wf-form4_167666926287264.xml
FORM 4
X0306
4
2023-02-15
0
0001125345
MACROGENICS INC
MGNX
0001587477
Karrels James
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
SVP, CFO and Secretary
Employee stock option (right to buy)
4.82
2023-02-15
4
A
0
180000
0
A
2033-02-15
Common Stock
180000.0
180000
D
Restricted Stock Unit
0.0
2023-02-15
4
A
0
45000
0
A
Common Stock
45000.0
45000
D
12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
/s/ Lynn Cilinski, Attorney-in-Fact
2023-02-17